ArticleHuman vaccines & immunotherapeutics2022

Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines.

Guy Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.